Versant Vantage II, L.P. is 10% Owner at Century Therapeutics, Inc. (IPSC). They have made 1 open-market trade across 1 company since 2021, most recently 2021-12-23.
CIK 0001832235
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2.0M since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IPSC | 12,545,810 | $17.3M |
Shares reported on the most recent Form 4, priced at the 2021-12-28 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IPSC | BUY | 2021-06-22 | 2021-06-23 | $20.00 | $2.0M | +9.3% | +17.0% | -16.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.